Therapeuticsmd Inc
(TXMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,115 | 6,069 | 5,745 | 5,059 | 5,047 |
| Receivables | 3,665 | 3,743 | 2,996 | 3,562 | 3,323 |
| TOTAL | $14,503 | $13,461 | $12,512 | $12,259 | $12,154 |
| Non-Current Assets | |||||
| Intangibles | 3,914 | 4,043 | 4,138 | 4,321 | 4,428 |
| Other Non-Current Assets | 20,254 | 21,000 | 21,586 | 22,242 | 22,970 |
| TOTAL | $24,168 | $25,043 | $25,724 | $26,563 | $27,398 |
| Total Assets | $38,671 | $38,504 | $38,236 | $38,822 | $39,552 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 263 | 350 | 176 | 258 | 234 |
| Accrued Expenses | 2,015 | 1,590 | 1,780 | 2,127 | 2,818 |
| TOTAL | $4,945 | $4,662 | $4,741 | $5,166 | $5,976 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,282 | 6,550 | 6,755 | 6,286 | 6,482 |
| TOTAL | $6,282 | $6,550 | $6,755 | $6,286 | $6,482 |
| Total Liabilities | $11,227 | $11,212 | $11,496 | $11,452 | $12,458 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,574 | 11,574 | 11,574 | 11,574 | 11,532 |
| Common Shares | 11 | 11 | 11 | 11 | 11 |
| Retained earnings | -951,772 | -951,924 | -952,475 | -951,822 | -952,074 |
| TOTAL | $27,444 | $27,292 | $26,740 | $27,370 | $27,094 |
| Total Liabilities And Equity | $38,671 | $38,504 | $38,236 | $38,822 | $39,552 |